U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C20H16N6S
Molecular Weight 372.446
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AS-601245

SMILES

N#CC(C1=NC2=CC=CC=C2S1)C3=NC(NCCC4=CC=CN=C4)=NC=C3

InChI

InChIKey=RCYPVQCPYKNSTG-UHFFFAOYSA-N
InChI=1S/C20H16N6S/c21-12-15(19-25-17-5-1-2-6-18(17)27-19)16-8-11-24-20(26-16)23-10-7-14-4-3-9-22-13-14/h1-6,8-9,11,13,15H,7,10H2,(H,23,24,26)

HIDE SMILES / InChI

Molecular Formula C20H16N6S
Molecular Weight 372.446
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 10:04:47 UTC 2023
Edited
by admin
on Sat Dec 16 10:04:47 UTC 2023
Record UNII
Y9A2N9O85G
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AS-601245
Common Name English
2-BENZOTHIAZOLEACETONITRILE, .ALPHA.-(2-((2-(3-PYRIDINYL)ETHYL)AMINO)-4-PYRIMIDINYL)-
Systematic Name English
AS601245
Code English
SAPK INHIBITOR V
Common Name English
JNK INHIBITOR V
Common Name English
Code System Code Type Description
CAS
861411-83-8
Created by admin on Sat Dec 16 10:04:47 UTC 2023 , Edited by admin on Sat Dec 16 10:04:47 UTC 2023
ALTERNATIVE
EPA CompTox
DTXSID401026023
Created by admin on Sat Dec 16 10:04:47 UTC 2023 , Edited by admin on Sat Dec 16 10:04:47 UTC 2023
PRIMARY
FDA UNII
Y9A2N9O85G
Created by admin on Sat Dec 16 10:04:47 UTC 2023 , Edited by admin on Sat Dec 16 10:04:47 UTC 2023
PRIMARY
CAS
345987-15-7
Created by admin on Sat Dec 16 10:04:47 UTC 2023 , Edited by admin on Sat Dec 16 10:04:47 UTC 2023
PRIMARY
PUBCHEM
10109823
Created by admin on Sat Dec 16 10:04:47 UTC 2023 , Edited by admin on Sat Dec 16 10:04:47 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY